The VA’s recruiting follows an announcement from the U.S. Defense Department in September that it has partnered with AstraZeneca to recruit volunteers at five of its medical facilities. The Defense Department has also signed an agreement with another vaccine developer, though it won’t release the company’s name, Army Lt. Gen. Ronald Place, head of the Defense Health Agency, told Kaiser Health News.
Of the 20 medical centers, 17 are part of Johnson & Johnson’s trial, and the others are for Moderna, AstraZeneca and Pfizer.
The military provides a “rich opportunity” to find volunteers from Black communities and other minorities that clinicians have historically struggled to recruit, Rear Adm. Thomas Cullison, a physician and former deputy surgeon general for the Navy, told Kaiser Health News.
No service members will be required to participate in the trials, but volunteers will be paid by the drugmaker for their respective trial.
Read the full article here.
More articles on pharmacy:
CVS CEO to step down, hand reins to Aetna chief
Allogene reports patient death tied to its CAR-T drug
Sandoz, Civica Rx ship first drug to US hospitals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.